These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21876251)

  • 1. What to look for beyond "pathogenic" factors in senile dementia? A functional deficiency of Ca²⁺ signaling.
    Chen M; Nguyen HT; Sawmiller DR
    J Alzheimers Dis; 2011; 27(4):679-89. PubMed ID: 21876251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ signaling down-regulation in ageing and Alzheimer's disease: why is Ca2+ so difficult to measure?
    Chen M; Fernandez HL
    Cell Calcium; 1999; 26(3-4):149-54. PubMed ID: 10598279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific truth or false hope? Understanding Alzheimer's disease from an aging perspective.
    Chen M; Maleski JJ; Sawmiller DR
    J Alzheimers Dis; 2011; 24(1):3-10. PubMed ID: 21178284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome.
    Goodison WV; Frisardi V; Kehoe PG
    J Alzheimers Dis; 2012; 30 Suppl 2():S269-82. PubMed ID: 22377784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.
    Yu JT; Chang RC; Tan L
    Prog Neurobiol; 2009 Nov; 89(3):240-55. PubMed ID: 19664678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
    Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM
    J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease].
    Zhang JT
    Yao Xue Xue Bao; 1993; 28(9):641-6. PubMed ID: 8010007
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer movement re-examined 25 years later: is it a "disease" or a senile condition in medical nature?
    Chen M; Fernandez HL
    Front Biosci; 2001 Aug; 6():E30-40. PubMed ID: 11502485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain aging and Alzheimer's disease; use it or lose it.
    Swaab DF; Dubelaar EJ; Hofman MA; Scherder EJ; van Someren EJ; Verwer RW
    Prog Brain Res; 2002; 138():343-73. PubMed ID: 12432778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
    Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis.
    Landfield PW; Thibault O; Mazzanti ML; Porter NM; Kerr DS
    J Neurobiol; 1992 Nov; 23(9):1247-60. PubMed ID: 1469387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium ions in neuronal degeneration.
    Wojda U; Salinska E; Kuznicki J
    IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of histone acetylation in age-associated memory impairment and Alzheimer's disease.
    Stilling RM; Fischer A
    Neurobiol Learn Mem; 2011 Jul; 96(1):19-26. PubMed ID: 21540120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease.
    Hung CH; Ho YS; Chang RC
    Ageing Res Rev; 2010 Oct; 9(4):447-56. PubMed ID: 20553970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+ release via ryanodine receptors and Ca2+ entry: major mechanisms in NAADP-mediated Ca2+ signaling in T-lymphocytes.
    Langhorst MF; Schwarzmann N; Guse AH
    Cell Signal; 2004 Nov; 16(11):1283-9. PubMed ID: 15337527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells.
    Lessard CB; Lussier MP; Cayouette S; Bourque G; Boulay G
    Cell Signal; 2005 Apr; 17(4):437-45. PubMed ID: 15601622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models.
    Stutzmann GE; Smith I; Caccamo A; Oddo S; Parker I; Laferla F
    Ann N Y Acad Sci; 2007 Feb; 1097():265-77. PubMed ID: 17413028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case of Alzheimer's disease with gastric antral vascular ectasia presenting severe anemia].
    Ukai K; Mizuno Y; Ito T; Ozaki K; Tomita K
    Seishin Shinkeigaku Zasshi; 2008; 110(9):739-44. PubMed ID: 19068746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative study of neurofibrillary tangles in subdivisions of the hippocampus. CA2 as a special area in normal aging and senile dementia of the Alzheimer type.
    Mizutani T; Shimada H
    Acta Pathol Jpn; 1991 Aug; 41(8):597-603. PubMed ID: 1750357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.